Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 25 - Drugs for disorders of the nervous system
Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
12/2010
12/29/2010CN1977868B Ginkgo biloba leaf total terpene lactone extract, and its preparing method, medicinal composition and use
12/29/2010CN1968691B Composition for acceleration of alcohol metabolism or recuperation from fatigue through gluconeogenesis
12/29/2010CN1922139B Bicyclic amide derivatives
12/29/2010CN1902196B Thiazole derivative
12/29/2010CN1867328B Use of lipid glyceride in preparing medicine for treatment of neurodegenerative conditions
12/29/2010CN1780829B Fluoro- and trifluoroalkyl-containing heterocyclic sulfonamide inhibitors of beta amyloid production and derivatives thereof
12/29/2010CN101932585A Substituted spirocyclic piperidine derivatives as histamine-3 (h3) receptor ligands
12/29/2010CN101932578A Gamma secretase modulators
12/29/2010CN101932574A 1,2,4,-triazin-3,5-dione compounds for treating disorders that respond to modulation of the dopamine d3 receptor
12/29/2010CN101932563A Solid forms of (s)-2-amino-3-(4-(2-amino-6-((r)-2,2,2-trifluoro-1-(3'-methoxybiphenyl-4-yl)ethoxy)pyrimidin-4-yl)phenyl)propanoic acid and methods of their use
12/29/2010CN101932551A Derivatives of aminoalkanols, method of obtaining of aminoalkanols and their use
12/29/2010CN101932327A Dosing regimen associated with long acting injectable paliperidone esters
12/29/2010CN101932323A Use of 3, 11b-cis-dihydrotetrabenazine in the treatment of multiple sclerosis and autoimmune myelitis
12/29/2010CN101932316A Pharmaceuticals and the production and use thereof in the treatment of painful neuropathies
12/29/2010CN101932314A New pharmaceutical formulation comprising cannabidiol and tetrahydrocannabidivarin
12/29/2010CN101932307A Compositions for treating parkinson's disease
12/29/2010CN101928745A Preparation method and applications of ant polypeptide
12/29/2010CN101928706A Technology for regulating up expression of ARE elements in DRD1 (Dopamine Receptor D1) mRNA 3-end non-coding region by stabilizing DRD1 mRNA
12/29/2010CN101928655A Schisandra chinensis health protection wine and preparation method thereof
12/29/2010CN101928329A Tripeptide boric acid (ester) compound and preparation method and application thereof
12/29/2010CN101928279A 3-amino-2-pyrones cyclooxygenase inhibitors as well as preparation method and application thereof
12/29/2010CN101928269A Crystalline base of escitalopram and orodispersible tablets comprising escitalopram base
12/29/2010CN101928259A 2-arylthiazole derivative and medicament composition thereof
12/29/2010CN101928241A 2-mercaptopentancarboxylic acid derivatives, the method for preparing them and the pharmaceutical compositions containing them
12/29/2010CN101928234A 6/7-(hetero)aryl-N-hydroxyl hexanamide/heptamide compounds and method for preparing same
12/29/2010CN101928230A Improved synthesis scheme for lacosamide
12/29/2010CN101926981A Methods of treating neurological conditions with hematopoietic growth factors
12/29/2010CN101926980A Application of cytotoxin (CTX1) from snake venom to preparation of medicament for rehabilitating
12/29/2010CN101926972A Medicament for treating headache and preparation method thereof
12/29/2010CN101926971A Medicament for treating insomnia and preparation method thereof
12/29/2010CN101926969A Traditional Chinese medicine composition for treatment of cervical spondylopathy and preparation method thereof
12/29/2010CN101926950A Brain-invigorating traditional Chinese medicine composite and preparation method and detection method thereof
12/29/2010CN101926945A Natural plant health care product capable of calming heart, refreshing mind, tonifying brain and improving intellectual development and preparation method thereof
12/29/2010CN101926938A Drug for curing tinnituscerebri
12/29/2010CN101926936A Tibetan medicinal health-care product
12/29/2010CN101926929A Traditional Chinese medicine for treating vascular dementia and preparation method thereof
12/29/2010CN101926911A Chinese medicinal composition for relieving pain and preparation method thereof
12/29/2010CN101926902A Medicinal composition for treating mild cognitive impairment
12/29/2010CN101926869A Medicament for treating dizziness and headache and preparation method thereof
12/29/2010CN101926865A Spina date seed depression-resolving and nerve-soothing composition and preparation method thereof
12/29/2010CN101926864A Method for producing wry mouth treatment powder
12/29/2010CN101926863A Method for identifying Nigella glandulifera Freyn medicinal material
12/29/2010CN101926835A Method for extracting gingko total terpene lactones and injection containing same
12/29/2010CN101926826A Method for extracting active ingredients from sea horse
12/29/2010CN101926803A Application of quinazoline compounds
12/29/2010CN101926802A Application of quinazoline compounds
12/29/2010CN101926790A (-)-epigallocatechin gallate composition and application
12/29/2010CN101926785A Medicinal controlled release preparation for treating parkinsonism and preparation method thereof
12/29/2010CN101926783A Drug slow control releaser and preparation method thereof
12/29/2010CN101926759A Idebenone injection containing 2-hydroxylpropyl-beta-cyclodextrin and preparation method thereof
12/29/2010CN101926505A Caffeine electronic cigarette liquid
12/29/2010CN101530410B Application of oligomeric proantho cyanidins in preparing products resisting vascular dementia
12/29/2010CN101445504B Dioxane-2-alkyl carbamates derivatives
12/29/2010CN101411800B Medicament for treating anxiety symptoms
12/29/2010CN101406668B Chinese medicinal composition for treating headache and dizzy, and preparation method thereof
12/29/2010CN101402691B Preparation method for prepared rehmannia root polysaccharide
12/29/2010CN101244127B Medicament for treating vascular dementia
12/29/2010CN101214270B Acanthopanax senticosus effective fraction extract, preparation and application thereof
12/29/2010CN101209288B Corydalis decumbentis orally disintegrating tablets
12/29/2010CN101205234B Curcumin-zinc compound as well as solid dispersion preparation and uses thereof
12/29/2010CN101200465B Decahydronaphthalene compounds and medical uses thereof
12/29/2010CN101190289B Traditional Chinese medicine for treating combined hemorrhoid postoperative edema pain
12/29/2010CN101120784B Brain tonic food and preparation method thereof
12/29/2010CN101098702B Drugs, food or drink for improving pancreatic functions
12/29/2010CN101077110B Health-care tea and its making method
12/29/2010CA2766809A1 Protease inhibitors, compositions and methods of use
12/29/2010CA2766387A1 Novel thiophenecarboxamide derivative and pharmaceutical use thereof
12/29/2010CA2766154A1 Novel fumarate salts of a histamine h3 receptor antagonist
12/29/2010CA2766107A1 A method for the treatment, alleviation of symptoms of, relieving, improving and preventing a cognitive disease, disorder or condition
12/29/2010CA2765815A1 Treatment of down syndrome gene related diseases by inhibition of natural antisense transcript to a down syndrome gene
12/29/2010CA2765692A1 Novel azabicyclohexanes
12/29/2010CA2764665A1 Compositions for treating drug addiction and improving addiction-related behavior
12/29/2010CA2764475A1 Crystals
12/29/2010CA2761427A1 A pharmaceutical composition
12/28/2010USRE42014 Pharmaceutical compositions
12/28/2010US7858824 Aralkyltetrahydropyridines, their preparation and pharmaceutical compositions containing them
12/28/2010US7858820 Easy to process and are highly stable on storage; nutraceuticals; dietetics; anions of inner salts contribute to therapeutic and nutritional value of compound; human and animal food/feed supplement; dosage
12/28/2010US7858786 Pyrimidines and pyrazines useful as modulators of ion channels
12/28/2010US7858776 (2,3-cis)-3-amino-2-phenyl-2,3-dihydro-1,5-benzoxazepin-4(5H)-one; for treatment of neurological disorders related to amyloid beta protein production such as Alzheimer's disease; inhibit gamma secretase and thereby inhibit the production of amyloid beta protein
12/28/2010US7858658 5'-chloro-N-[3,3,3-trifluoro-2-(trifluoromethyl)-1S-(hydroxymethyl)propyl]thiophene-2'-sulfonamide, used for the treatment of Alzheimer's Disease and Down's syndrome
12/28/2010US7858655 synergistic mixtures reduce damage to neurons after a neurodegenerative insult; time-release agents; antiischemic agents; amyotrophic lateral slerosis (ALS), Alzheimer's disease, Parkinson's disease, Hunntington's disease, multiple sclerosis
12/28/2010US7858641 melanocortin-4 receptor (MC4-R) agonists such as (3R,5S)-N-(2-{2-[2-fluoro-4-(methyloxy)phenyl]ethyl}-1-oxo-1,2-dihydroisoquinolin-6-yl)-3,5-dimethyl-N'-[(1S,2S,3S,5R)-2,6,6-trimethylbicyclo[3.1.1]hept-3-yl]piperazine-1-carboximidamide, used for the treatment of obesity or diabetes
12/28/2010US7858631 such as (3R,5S)-N-(3-{2-[2-fluoro-4-(methyloxy)phenyl]ethyl}-4-oxo-3,4-dihydropyrido[2,3-d]pyrimidin-7-yl)-3,5-dimethyl-N'-[(1S,2S,3S,5R)-2,6,6-trimethylbicyclo[3.1.1]hept-3-yl]piperazine-1-carboximidamide, used as melanocortin-4 receptor (MC4-R) agonists, for the treatment of obesity or diabetes
12/28/2010US7858622 calcitonin gene related peptide antagonists such as [(3-[4-amino-3-chloro-5-(trifluoromethyl)phenyl]-1-[4-[1-(3-ethoxy-3-oxopropyl)piperidin-4-yl]piperidin-1-yl]-1-oxopropan-2-yl]4-(3-oxo-5-phenyl-1H-1,2,4-triazol-2-yl)piperidine-1-carboxylate; headaches; diabetes; irritable bowel syndrome; hot flashes
12/28/2010US7858617 2-hexadecyloxy-6-methyl-4H-3,1-benzoxazin-4-one; inhibition of a lipase, esterase or phosphatase enzyme
12/28/2010US7858605 Oral contraceptives to prevent pregnancy and diminish premenstrual symptomatology
12/28/2010US7858603 neuroprotectants such as 1,4-cholestadien-3-one oxime, used for the treatment of neurodegenerative diseases
12/28/2010US7858602 identifying a patient who is exhibiting signs of Alzheimer's disease;measuring and identifying carbonic anhydrase enzymes, than administering non-toxic amount of vitamin D3 to promotes the natural generation of the cell-specific carbonic anhydrase enzymes; aging resistance
12/28/2010US7858577 Use of the long pentraxin PTX3 for the treatment of diseases caused by an altered activation of the growth factor FGF-2
12/23/2010WO2010148413A2 Protease variants
12/23/2010WO2010148177A2 Compounds, compositions, methods of synthesis, and methods of treatment
12/23/2010WO2010147975A1 Gamma secretase modulators
12/23/2010WO2010147973A1 Gamma secretase modulators
12/23/2010WO2010147938A2 Reversal of l-dopa-induced dyskinesia by neuronal nicotinic receptor ligands
12/23/2010WO2010147803A2 Adult cerebellum-derived neural stem cells and compositions and methods for producing oligodendrocytes
12/23/2010WO2010147677A2 Treatment of inflammatory disorders, cardiovascular diseases and acute ischemic brain stroke with ozone
12/23/2010WO2010147484A1 Compositions and methods for treatment of multiple sclerosis
12/23/2010WO2010147434A2 Use of toosendanin or melia azedarach extracts for preventing or treating dementia
12/23/2010WO2010147234A1 Diarylamide-spirodiamine derivative
12/23/2010WO2010147184A1 Prophylactic and/or therapeutic agent for dysmenorrhea
1 ... 400 401 402 403 404 405 406 407 408 409 410 411 412 413 414 415 416 417 418 419 420 ... 1833